Condition: Heart Failure · Sponsor: CVRx, Inc.
The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Grandview Medical Center | Birmingham, Alabama, United States | — |
| Chan Heart Rhythm Institute | Mesa, Arizona, United States | — |
| Akil Loli Consulting LLC | Phoenix, Arizona, United States | — |
| Cabrillo Cardiology Research Group | Oxnard, California, United States | — |
| COR Healthcare Medical Associates | Torrance, California, United States | — |
| Aurora Denver Cardiology Associates | Aurora, Colorado, United States | — |
| South Denver Cardiology Associates, P.C. | Littleton, Colorado, United States | — |
| Medstar Health Research Insitutute | Washington D.C., District of Columbia, United States | — |
| The George Washington University Medical Faculty Associates | Washington D.C., District of Columbia, United States | — |
| Orlando Cardiac & Vascular Specialists | Altamonte Springs, Florida, United States | — |
| Orlando Heart and Vascular Institute | Altamonte Springs, Florida, United States | — |
| Lakewood Cardiovascular | Bradenton, Florida, United States | — |
+ 34 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.